Company info

What is Counsyl?

Counsyl is a DNA testing and genetic counseling service. We're committed to helping you understand your DNA and how it can inform important health decisions. Whether it’s starting a family or evaluating risk for cancer, Counsyl's DNA tests provide you with early awareness about genetic conditions, so you can live informed and prepare for the future.

Every Counsyl test starts with a conversation with your healthcare provider and includes a consultation with a board-certified genetic counselor. Our automated clinical lab enables results delivery at industry-leading speeds and improved cost efficiency. Counsyl has screened more than 750,000 patients and served more than 10,000 health care professionals.

Company background

  • Founded: 2007
  • Product launch: 2009
  • Funding: $102M from Founders Fund, Pilot Growth Equity, Goldman Sachs Asset Management, Felicis Ventures, David Drummond and private investors.
  • Executives: Ramji Srinivasan, Co-founder & CEO; Dr. Eric Evans, Co-founder & Chief Science Officer; Rishi Kacker, Co-founder & VP of Products; Dr. James Goldberg, Chief Medical Officer; Joel Jung, Chief Financial Officer; Matthew Meyer, SVP of Corporate Development; John Tan, SVP of Operations; Peter Soparkar, General Counsel
  • Board of Directors: Ramji Srinivasan; Rishi Kacker; Eric Evans
  • >750,000 patients screened
  • 50+ board-certified genetic counselors
  • Working with more than 10,000 medical professionals and a network of insurance providers

Laboratory licensing

CLF 00338555
New York
PFI 8535
Rhode Island

Counsyl has renamed its products effective July 19, 2017. The Family Prep Screen is now the Foresight Carrier Screen. The Informed Pregnancy Screen is now the Prelude Prenatal Screen. The Inherited Cancer Screen is now the Reliant Cancer Screen.

The new names now appear on all communications from Counsyl. If you have any questions, please contact Counsyl directly.

Live Chat